IRIS Accounts Production v26.1.10.61 SC196876 Board of Directors 1.11.24 31.10.25 31.10.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC1968762024-10-31SC1968762025-10-31SC1968762024-11-012025-10-31SC1968762023-10-31SC1968762023-11-012024-10-31SC1968762024-10-31SC196876ns15:Scotland2024-11-012025-10-31SC196876ns14:PoundSterling2024-11-012025-10-31SC196876ns10:Director12024-11-012025-10-31SC196876ns10:PrivateLimitedCompanyLtd2024-11-012025-10-31SC196876ns10:SmallEntities2024-11-012025-10-31SC196876ns10:AuditExempt-NoAccountantsReport2024-11-012025-10-31SC196876ns10:SmallCompaniesRegimeForDirectorsReport2024-11-012025-10-31SC196876ns10:SmallCompaniesRegimeForAccounts2024-11-012025-10-31SC196876ns10:FullAccounts2024-11-012025-10-31SC19687612024-11-012025-10-31SC196876ns10:Director22024-11-012025-10-31SC196876ns10:CompanySecretary12024-11-012025-10-31SC196876ns10:RegisteredOffice2024-11-012025-10-31SC196876ns5:CurrentFinancialInstruments2025-10-31SC196876ns5:CurrentFinancialInstruments2024-10-31SC196876ns5:ShareCapital2025-10-31SC196876ns5:ShareCapital2024-10-31SC196876ns5:SharePremium2025-10-31SC196876ns5:SharePremium2024-10-31SC196876ns5:RetainedEarningsAccumulatedLosses2025-10-31SC196876ns5:RetainedEarningsAccumulatedLosses2024-10-31SC196876ns5:NetGoodwill2024-11-012025-10-31SC196876ns5:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-31SC196876ns5:NetGoodwill2024-10-31SC196876ns5:NetGoodwill2025-10-31SC196876ns5:NetGoodwill2024-10-31SC196876ns5:LandBuildings2024-10-31SC196876ns5:PlantMachinery2024-10-31SC196876ns5:LandBuildings2024-11-012025-10-31SC196876ns5:PlantMachinery2024-11-012025-10-31SC196876ns5:LandBuildings2025-10-31SC196876ns5:PlantMachinery2025-10-31SC196876ns5:LandBuildings2024-10-31SC196876ns5:PlantMachinery2024-10-31SC196876ns5:CostValuation2024-10-31SC196876ns5:DisposalsRepaymentsInvestments2025-10-31SC196876ns5:CostValuation2025-10-31SC196876ns5:WithinOneYearns5:CurrentFinancialInstruments2025-10-31SC196876ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-31
REGISTERED NUMBER: SC196876 (Scotland)















Unaudited Financial Statements for the Year Ended 31 October 2025

for

Bishopmill Pharmacy Ltd

Bishopmill Pharmacy Ltd (Registered number: SC196876)






Contents of the Financial Statements
for the Year Ended 31 October 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Bishopmill Pharmacy Ltd

Company Information
for the Year Ended 31 October 2025







DIRECTORS: A Smith
Mrs J Smith





SECRETARY:





REGISTERED OFFICE: 6 Kennedy Place
Bishopmill
Elgin
MORAY
IV30 4EL





REGISTERED NUMBER: SC196876 (Scotland)





ACCOUNTANTS: Stag Accountancy & Tax Services
6 Kintrae Rise
Elgin
MORAY
IV30 5ND

Bishopmill Pharmacy Ltd (Registered number: SC196876)

Balance Sheet
31 October 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 58,882 49,740
Investments 6 - 9,507
58,882 59,247

CURRENT ASSETS
Stocks 86,348 80,867
Debtors 7 855,675 835,452
Cash at bank and in hand 512,883 626,828
1,454,906 1,543,147
CREDITORS
Amounts falling due within one year 8 827,455 986,974
NET CURRENT ASSETS 627,451 556,173
TOTAL ASSETS LESS CURRENT LIABILITIES 686,333 615,420

CAPITAL AND RESERVES
Called up share capital 50,125 50,125
Share premium 600 600
Retained earnings 635,608 564,695
686,333 615,420

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Bishopmill Pharmacy Ltd (Registered number: SC196876)

Balance Sheet - continued
31 October 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2026 and were signed on its behalf by:





A Smith - Director


Bishopmill Pharmacy Ltd (Registered number: SC196876)

Notes to the Financial Statements
for the Year Ended 31 October 2025

1. STATUTORY INFORMATION

Bishopmill Pharmacy Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Bishopmill Pharmacy Ltd (Registered number: SC196876)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 19 (2024 - 18 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 November 2024
and 31 October 2025 266,122
AMORTISATION
At 1 November 2024
and 31 October 2025 266,122
NET BOOK VALUE
At 31 October 2025 -
At 31 October 2024 -

Bishopmill Pharmacy Ltd (Registered number: SC196876)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 November 2024 122,718 199,354 322,072
Additions - 24,851 24,851
At 31 October 2025 122,718 224,205 346,923
DEPRECIATION
At 1 November 2024 82,465 189,867 272,332
Charge for year 5,155 10,554 15,709
At 31 October 2025 87,620 200,421 288,041
NET BOOK VALUE
At 31 October 2025 35,098 23,784 58,882
At 31 October 2024 40,253 9,487 49,740

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 November 2024 9,507
Disposals (9,507 )
At 31 October 2025 -
NET BOOK VALUE
At 31 October 2025 -
At 31 October 2024 9,507

Bishopmill Pharmacy Ltd (Registered number: SC196876)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 207,013 207,553
Other debtors 648,662 627,899
855,675 835,452

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts - 2,810
Trade creditors 221,201 230,944
Taxation and social security 33,984 99,596
Other creditors 572,270 653,624
827,455 986,974